Consistent with these findings, our molecular docking and dynamics analysis revealed a stable interaction between rabeprazole and SRC, suggesting that rabeprazole may influence SRC activity, thereby contributing to the development of osteoporosis. This evidence concerns the gene SRC and osteoporosis.